Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-binding motif protein Y-linked family 1 member D (RBMY1D) is a testis-specific, Y chromosome-encoded RNA-binding protein that contains an N-terminal RNA recognition motif (RRM) and several C-terminal SRGY (serine, arginine, glycine, tyrosine) motifs[1][4][5]. It belongs to a family of related RBMY genes located in the AZFb azoospermia factor region of the Y chromosome[3][5]. RBMY1D and its paralogs are essential for normal sperm development and act as pre-mRNA splicing regulators, participating in the regulation of alternative splicing events during spermatogenesis[1][3]. It recognizes RNA stem-loop structures in a sequence- and shape-dependent manner via its RRM domain[1]. Defects or deletions affecting the RBMY gene family are strongly associated with male infertility, particularly azoospermia and Y chromosome microdeletion syndromes[3]. There is currently no evidence that RBMY1D is a direct therapeutic target or that there are drugs modulating its function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-binding motif protein Y-linked family 1 member D (RBMY1D).